Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Regeneron seeks clarity on confirmatory trials after FDA hurdle
Regeneron's Andres Sirulnik says blood cancer medicine odronextamab enrollment is going fine, days after FDA rejection.
Annalee Armstrong
Mar 29, 2024 5:00am
#FierceMadness: The Best Biotech Name Tournament—RESULTS
Mar 29, 2024 9:31am
John Cox gets new biotech CEO gig at Dyne—Chutes & Ladders
Mar 29, 2024 9:30am
'The Top Line': The top money raisers in biotech
Mar 29, 2024 9:00am
Ypsomed hands off insulin pen needle business
Mar 28, 2024 11:59am
Fierce Biotech Layoff Tracker '24: Bayer, BMS & more
Mar 28, 2024 11:10am
Medtech News
Exact shows off its pill-on-a-string test for esophageal cancer
Mar 28, 2024 11:00am
FDA to ban electric shock devices for behavior control—again
Mar 27, 2024 11:49am
Medtronic nets FDA approval for evolved Evolut TAVR valve
Mar 27, 2024 10:06am
Abbott nets European approval for 6-year cardiac monitor implant
Mar 26, 2024 12:49pm
See More Medtech News